Total Payments
$12,437
2024 Payments
$3,272
Companies
43
Transactions
586
Medicare Patients
2,433
Medicare Billing
$135,112
Payment Breakdown by Category
Food & Beverage$12,375 (99.5%)
Education$61.95 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,375 | 585 | 99.5% |
| Education | $61.95 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,428 | 56 | $0 (2024) |
| Novo Nordisk Inc | $1,355 | 74 | $0 (2024) |
| Lilly USA, LLC | $1,345 | 84 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $841.09 | 35 | $0 (2024) |
| GlaxoSmithKline, LLC. | $832.85 | 29 | $0 (2024) |
| ABBVIE INC. | $817.68 | 54 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $568.17 | 26 | $0 (2024) |
| PFIZER INC. | $475.15 | 27 | $0 (2024) |
| Exact Sciences Corporation | $412.48 | 17 | $0 (2024) |
| Astellas Pharma US Inc | $344.43 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,272 | 143 | Amgen Inc. ($492.83) |
| 2023 | $3,025 | 147 | Lilly USA, LLC ($423.37) |
| 2022 | $2,869 | 142 | Novo Nordisk Inc ($354.02) |
| 2021 | $3,270 | 154 | Amgen Inc. ($474.45) |
All Payment Transactions
586 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Bone Health | ||||||
| 12/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.56 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: PAIN | ||||||
| 11/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.30 | General |
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Cardio-renal | ||||||
| 11/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.09 | General |
| 10/31/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Endocrinology | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 735 | 816 | $111,212 | $44,376 |
| 2022 | 11 | 636 | 699 | $93,311 | $38,407 |
| 2021 | 12 | 565 | 639 | $72,220 | $29,887 |
| 2020 | 13 | 497 | 574 | $64,630 | $22,444 |
Total Patients
2,433
Total Services
2,728
Medicare Billing
$135,112
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 189 | $42,525 | $15,412 | 36.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 113 | 113 | $20,792 | $8,028 | 38.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 69 | 69 | $16,146 | $7,932 | 49.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 39 | 39 | $13,728 | $5,774 | 42.1% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 116 | 116 | $4,640 | $1,873 | 40.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 17 | 17 | $1,275 | $1,219 | 95.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 66 | 66 | $2,376 | $1,071 | 45.1% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 30 | 45 | $2,520 | $1,053 | 41.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 19 | $2,926 | $850.58 | 29.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $972.00 | $591.12 | 60.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $600.00 | $394.08 | 65.7% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 113 | 113 | $2,712 | $177.60 | 6.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 106 | 165 | $37,125 | $13,462 | 36.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 83 | 83 | $19,422 | $9,749 | 50.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 97 | 97 | $17,848 | $7,336 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 29 | $4,466 | $1,578 | 35.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 92 | 92 | $3,680 | $1,532 | 41.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 83 | 83 | $2,988 | $1,359 | 45.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 32 | 32 | $3,008 | $1,166 | 38.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 16 | 16 | $1,180 | $1,086 | 92.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 18 | 19 | $1,026 | $592.28 | 57.7% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 17 | 18 | $1,008 | $440.50 | 43.7% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 65 | 65 | $1,560 | $106.24 | 6.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 74 | 109 | $24,532 | $9,781 | 39.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 55 | 55 | $12,870 | $6,660 | 51.7% |
About Maria Sorensen, PA-C
Maria Sorensen, PA-C is a Medical healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2015. The National Provider Identifier (NPI) number assigned to this provider is 1699145177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Maria Sorensen, PA-C has received a total of $12,437 in payments from pharmaceutical and medical device companies, with $3,272 received in 2024. These payments were reported across 586 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($12,375).
As a Medicare-enrolled provider, Sorensen has provided services to 2,433 Medicare beneficiaries, totaling 2,728 services with total Medicare billing of $135,112. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Miami, FL
- Active Since 09/28/2015
- Last Updated 09/28/2015
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1699145177
Products in Payments
- Otezla (Drug) $1,081
- NURTEC ODT (Drug) $734.68
- MOUNJARO (Drug) $712.48
- TRELEGY ELLIPTA (Drug) $607.65
- Kerendia (Drug) $568.17
- Ozempic (Drug) $563.29
- FARXIGA (Drug) $529.20
- Cologuard Collection Kit (Device) $412.48
- UBRELVY (Drug) $410.50
- Rybelsus (Drug) $371.88
- JARDIANCE (Drug) $316.50
- TRULICITY (Drug) $285.76
- GEMTESA (Drug) $278.22
- Vascepa (Drug) $249.63
- QULIPTA (Drug) $243.03
- BREZTRI (Drug) $209.91
- SHINGRIX (Biological) $204.51
- RYBELSUS (Drug) $203.96
- VOQUEZNA (Drug) $195.02
- ENTRESTO (Drug) $193.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Miami
Ms. Jeanelle King, Pa, PA
Medical — Payments: $317,615
Medical $317,615
Ilanit Samuels, Pa-C, PA-C
Medical — Payments: $200,992
Medical $200,992
Polina Radchenkova, Pa-C, PA-C
Medical — Payments: $17,105
Medical $17,105
Mrs. Anay Castro, Pa-C, PA-C
Medical — Payments: $15,049
Medical $15,049
Mr. Jesus Rodriguez, Pa-C, PA-C
Medical — Payments: $11,211
Medical $11,211
Pamela Kenyon, P.a, P.A
Medical — Payments: $10,821
Medical $10,821